- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Mark S. Brown
Insight 10 results
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Life Sciences Industry
Feature
January 15, 2021
General Counsel Internal Investigations Decision Tree for the Food and Beverage Industry
Client Alert
December 11, 2020
Department of Justice Vows Vigorous Enforcement of Clinical Trial Fraud
Client Alert
October 9, 2018
Cleanup on Title 5: Executive Agencies and Courts Begin to Unpack Lucia, as Litigants Eye Challenges to the Administrative State
Article · Source: American Bar Association Business Law Today
September 26, 2018
Cleanup on Title 5: Executive Agencies and Courts Begin to Unpack Lucia, as Litigants Eye Challenges to the Administrative State
Client Alert
August 31, 2017
President Trump Signs FDA User Fee Reauthorization Bill into Law – A Relief for the Medical Device Industry
Client Alert
June 10, 2016
FDA Announces New “Compassionate Use” Approval Process for Investigational Drugs
Client Alert
January 26, 2016
FDA Issues New Cybersecurity Guidance for Medical Device Manufacturers
Article · Source: Washington Legal Foundation
March 27, 2015
First Circuit Breathes New Life Into Branded Drug Preemption Defense